New pathway in rheumatic mitral valve disease: Cytochrome P450 and glutathione S transferase isozyme expression

Basit Öğe Kaydı
dc.contributor.authorSimsek E.
dc.contributor.authorSimsek G.
dc.contributor.authorSoyal M.F.T.
dc.contributor.authorKaygin P.
dc.contributor.authorOguztuzun S.
dc.contributor.authorDuzgun A.C.
dc.contributor.authorSarialtin S.
dc.date.accessioned2021-01-14T18:11:16Z
dc.date.available2021-01-14T18:11:16Z
dc.date.issued2020
dc.departmentKKÜ
dc.description.abstractObjective: Cytochrome P450 (CYP)1A1, glutathione S-transferase pi (GSTP1) and omega (GSTO1) isozymes were evaluated and compared in patients with the diagnosis of rheumatic mitral valve disease and ischemic mitral valve insufficiency to find out the relationship of the oxidative stress with rheumatic mitral valve disease. Materials and methods: The control group consisted of patients operated on due to ischemic mitral valve insufficiency (group I, n:14) while study group consisted of the patients operated on with the diagnosis of rheumatic mitral valve disease (group II, n:29). Mitral valve materials were stained with hematoxylin and eosin. CYP1A1, GSTP1, and GSTO1 immunohistochemical markers were studied. Results: 20.7% of GSTP1 isozyme protein expression was seen in the study group; however, no expression was detected in the control group. This finding was statistically significant in terms of GSTP1 isozyme. No statistically significant differences in the level of GSTO1 and CYP1A1 protein expression between the study and control groups were observed. Conclusion: In this study, we found out that GSTP1 isozyme may be related to rheumatic mitral valve disease. A strategy that would help prevent oxidative stress in patients with rheumatic mitral valve disease can be a so valuable means to affect disease progression. © 2020 De Gruyter. All rights reserved.en_US
dc.identifier.doi10.1515/tjb-2019-0302
dc.identifier.endpage875en_US
dc.identifier.issn0250-4685
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85098950708
dc.identifier.scopusqualityQ3
dc.identifier.startpage869en_US
dc.identifier.trdizinid455019
dc.identifier.urihttps://doi.org/10.1515/tjb-2019-0302
dc.identifier.urihttps://hdl.handle.net/20.500.12587/12935
dc.identifier.volume45en_US
dc.identifier.wosWOS:000603517600029
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherDe Gruyter Open Ltden_US
dc.relation.ispartofTurkish Journal of Biochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCytochrome P450en_US
dc.subjectGlutathione S-transferaseen_US
dc.subjectGST isozyme expressionen_US
dc.subjectIschemic mitral valve insufficencyen_US
dc.subjectRheumatic mitral valve diseaseen_US
dc.titleNew pathway in rheumatic mitral valve disease: Cytochrome P450 and glutathione S transferase isozyme expressionen_US
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WOS İndeksli Yayınlar Koleksiyonu